A carregar...
T-PLL: another check on the venetoclax list?
In this issue of Blood, Boidol et al report a highly T-cell prolymphocytic leukemia (T-PLL)-specific response to the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax in an ex vivo high-throughput drug screen, as well as partial remissions (PRs) in 2 patients with relapsed/refractory (R/R) T-PLL and hi...
Na minha lista:
| Publicado no: | Blood |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721286/ https://ncbi.nlm.nih.gov/pubmed/29217697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-10-809673 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|